AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22521630
Drug: Intramuscular botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular botulinum toxin A
Trial: 8682116
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (atenolol + nifedipine)
Trial: 1899852
Drug: Alpha-interferon (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-interferon (7.5 MU/m2 three times weekly for 3 months, then 5 MU/m2 for 3 months, and 2.5 MU/m2 for 6 months)
Trial: 30252057
Drug: 11β‐MNTDC (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11β‐MNTDC (100, 200, 400, and 800 mg)
Trial: 30252057
Drug: 11β‐MNTDC (200,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11β‐MNTDC (200, 400, and 800 mg)
Trial: 29176264
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 1560 mg/d
Trial: 29176264
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 260 mg/d (low-dose group, control group)
Trial: 15094439
Drug: Radio-guided tumour
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radio-guided tumour excision after intratumoral injection of 99mTc-nanocolloid
Trial: 9052605
Drug: Endovaginal ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovaginal ultrasound (weekly vaginal probe ultrasound scans)
Trial: 8367670
Drug: IVER 400
RxNorm normalized name: Iver-On
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVER 400 plus DEC 1 mg.kg‐1 (12 patients)
Trial: 8367670
Drug: IVER 400
RxNorm normalized name: Iver-On
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVER 400 plus DEC 3 mg.kg‐1 (17 patients)
Trial: 8367670
Drug: IVER 400
RxNorm normalized name: Iver-On
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVER 400 plus DEC 6 mg.kg‐1 (10 patients)
Trial: 8367670
Drug: DEC 6
RxNorm normalized name: Zodryl DEC 60 Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC 6 mg.kg‐1 alone (5 patients)
Trial: 2738261
Drug: Sequential pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential pulse defibrillation
Trial: 26988949
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus prasugrel
Trial: 27845859
Drug: 25-hydroxyvitamin D
RxNorm normalized name: 25-hydroxyvitamin D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-hydroxyvitamin D (25-OHD) levels in women with MetS (35.26 ± 1.61 nmol/l)
Trial: 16790650
Drug: Levobupivacaine 0.125%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.125% and sufentanil 0.75 microg/mL with epinephrine 1:800,000
Trial: 16790650
Drug: Levobupivacaine 0.125%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.125% and sufentanil 0.75 microg/mL without epinephrine
Trial: 11103159
Drug: Cephalosporin antibiotic
RxNorm normalized name: Cephalosporium roseum
DrugBank: Cephalosporium roseum (DB10932)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalosporin antibiotic
Trial: 9396959
Drug: Sertraline or
RxNorm normalized name: sertraline Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline or paroxetine (SSRIs) for 6 weeks
Trial: 19747930
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of oxytocin
Trial: 20451523
Drug: Lesogaberan (65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lesogaberan (65 mg)
Trial: 18564348
Drug: 500 mcg
RxNorm normalized name: Nplate 500 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mcg alprostadil cream
Trial: 18564348
Drug: 700 mcg
RxNorm normalized name: L-Methylfolate Glucosamine 1700 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 mcg alprostadil cream
Trial: 18564348
Drug: 900 mcg
RxNorm normalized name: Belbuca 900 MCG Buccal Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mcg alprostadil cream
Trial: 16167910
Drug: Diclofenac hydroxyethyl
RxNorm normalized name: diclofenac hydroxyethylpyrrolidine 1.292 % Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac hydroxyethyl pyrrolidine (100 mg)
Trial: 12859696
Drug: losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan (50 mg o.d.)
Trial: 11130221
Drug: Prokinetic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prokinetic agents (cisapride, erythromycin, metoclopramide)
Trial: 8157039
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg (AT)
Trial: 8157039
Drug: Bendrofluazide 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide 5 mg (BFZ)
Trial: 8157039
Drug: Combined Atenolol
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined Atenolol 100 mg and Bendrofluazide 5 mg (AT/BFZ)
Trial: 8157039
Drug: Diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 5 mg (Dz)
Trial: 3538476
Drug: Inhaled piriprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled piriprost 1 mg
Trial: 26179891
Drug: Dietary counseling
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary counseling and n-3 PUFA supplementation (2.4 g/d) for 36 months
Trial: 23726602
Drug: Mizoribine (MZR)
RxNorm normalized name: Mizoribine
DrugBank: Mizoribine (DB12617)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine (MZR) after dose change
Trial: 23726602
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) after dose change
Trial: 18582179
Drug: d-MPH-ER 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-MPH-ER 20 mg/day
Trial: 18582179
Drug: d-MPH-ER 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-MPH-ER 30 mg/day
Trial: 18582179
Drug: d,l-MPH-ER 36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d,l-MPH-ER 36 mg/day
Trial: 16861611
Drug: GHRP-2 low
RxNorm normalized name: Dianeal Low Calcium 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRP-2 low dose (0.1 microg/kg per hour)
Trial: 16861611
Drug: GHRP-2 high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRP-2 high dose (1 mug/kg per hour)
Trial: 14561022
Drug: Acid suppressive
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acid suppressive therapy (AST)
Trial: 14561022
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (surgical and general internal medicine ward)
Trial: 8679353
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 10 ml with lignocaine
Trial: 1932606
Drug: Intravenous carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous carbimide doses of 0.1, 0.3, 0.6, and 1 mg kg‐1
Trial: 1932606
Drug: Oral carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral carbimide doses of 1 and 1.5 mg kg‐1
Trial: 1932606
Drug: Oral carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral carbimide doses of 0.3 and 1 mg kg‐1
Trial: 31927343
Drug: CVT‐301 84
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVT‐301 84 mg
Trial: 18075285
Drug: Lycopene supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene supplementation (10 mg/day)
Trial: 15379366
Drug: Imiquimod cream
RxNorm normalized name: Imiquimod Cream
DrugBank: Imiquimod (DB00724)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imiquimod cream 5%
Trial: 12142559
Drug: Adoptive immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adoptive immunotherapy with anti‐CD3‐expanded tumor vaccine draining lymph node lymphocytes (TVDLN) combined with systemic IL‐2 after vaccination with gene-modified autologous tumor cells.
Trial: 8610712
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (500 micrograms, nebulized, three times daily)
Trial: 8610712
Drug: Albuterol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (2.5 mg, nebulized, three times daily)
Trial: 1707333
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg b.i.d. of ketotifen
Trial: 1707333
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg b.i.d. of ketotifen
Trial: 7192125
Drug: fenbufen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fenbufen (1000 mg/d)
Trial: 7192125
Drug: acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: acetylsalicylic acid (ASA) (3600 mg/d)
Trial: 30427749
Drug: 15-valent pneumococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-valent pneumococcal conjugate vaccine (PCV15)
Trial: 20308765
Drug: Zinc and
RxNorm normalized name: Zinc and/or zinc compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc and multivitamin supplement (2mg/kg/day for 6 weeks)
Trial: 20308765
Drug: Only multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only multivitamin supplement
Trial: 15831778
Drug: 12-mg HHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-mg HHER q24h
Trial: 15831778
Drug: 3-mg HHIR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-mg HHIR q6h
Trial: 8919830
Drug: Low flow
RxNorm normalized name: high mallow flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low flow circuit (fresh gas flow 700 ml/min)
Trial: 332465
Drug: Sulfadiazine (SD)
RxNorm normalized name: Sulfadiazine
DrugBank: Sulfadiazine (DB00359)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfadiazine (SD) 1,000 MG/Trimethoprim (TM) 320 mg
Trial: 332465
Drug: Sulfamethoxazole (SM)
RxNorm normalized name: Sulfamethoxazole
DrugBank: Sulfamethoxazole (DB01015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole (SM) 1,600 mg/Trimethoprim 320 mg
Trial: 29258499
Drug: SMS education
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SMS education intervention (daily messages and weekly reminders)
Trial: 18713761
Drug: Mirtazapine 30
RxNorm normalized name: mirtazapine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine 30 mg
Trial: 19567093
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose (200 mg once a week for 4 weeks, then 100 mg once a week for 8 weeks for HD subgroup; 200 mg once a week for 4 weeks, then 200 mg once every other week for 8 weeks for PD subgroup)
Trial: 19567093
Drug: Oral medication
RxNorm normalized name: Oral Medication Syringe 3mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medication (ferrous succinate 200 mg tid for 12 weeks)
Trial: 19567093
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose (PD subgroup)
Trial: 19567093
Drug: EPO +
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO + intravenous iron sucrose
Trial: 16734581
Drug: Two two‐piece
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two two‐piece implants placed in a non‐submerged procedure
Trial: 16734581
Drug: Two two‐piece
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two two‐piece implants placed in the traditional submerged procedure
Trial: 16734581
Drug: Two one‐piece
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two one‐piece dental implants placed in the traditional non‐submerged procedure
Trial: 16734581
Drug: Microgap at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microgap at the crestal level in two‐piece implants
Trial: 15229957
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg twice weekly by subcutaneous injection
Trial: 9150822
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg paroxetine (n = 271)
Trial: 9150822
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg maprotiline (n = 273)
Trial: 9150822
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg paroxetine (n = 50)
Trial: 9150822
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg maprotiline (n = 40)
Trial: 8881802
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily for four to eight weeks (H pylori negative ulcers)
Trial: 8881802
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily plus amoxycillin 1 g twice daily for the first two weeks (H pylori positive ulcers)
Trial: 8881802
Drug: Omeprazole alone
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole alone for four to eight weeks while continuing NSAID therapy (H pylori positive ulcers)
Trial: 2805366
Drug: Topical anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anaesthesia of the nasal mucous membrane
Trial: 1099859
Drug: oestradiolvalerate/norgestrel sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oestradiolvalerate/norgestrel sequential therapy
Trial: 31169952
Drug: Spontaneous ovulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spontaneous ovulation monitored by urinary luteinising hormone (LH)
Trial: 31169952
Drug: Induced ovulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induced ovulation by administration of human chorionic gonadotrophin (hCG)
Trial: 26970975
Drug: HSS-Group (closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSS-Group (closed-loop system for propofol administration)
Trial: 26970975
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group (manual administration of propofol)
Trial: 19339805
Drug: Guidelines group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guidelines group (ARIA guidelines with ebastine as oral antihistamine)
Trial: 12859551
Drug: Free-choice treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free-choice treatment group
Trial: 16764547
Drug: Protein-enriched energy
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-enriched energy supplement
Trial: 15153734
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (3 instillations at 8-hourly intervals in 1 day)
Trial: 15153734
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (9 instillations at 8-hourly intervals in 3 days)
Trial: 11421903
Drug: Ebastine 20
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 20 mg once daily for 7 days
Trial: 9416721
Drug: Volume loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volume loading of 15 ml/kg lactated Ringer's solution
Trial: 9416721
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of etilefrine
Trial: 8495702
Drug: antibiotic (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antibiotic (1 day)
Trial: 8495702
Drug: antibiotic (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antibiotic (3 days)
Trial: 28724581
Drug: Triple-dose gadolinium
RxNorm normalized name: gadolinium
DrugBank: Gadolinium (DB12091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-dose gadolinium administration during MRI scans
Trial: 16582056
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT), 22 sessions
Trial: 12655445
Drug: Hydration solution
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydration solution with 100 mEq/l sodium (regimen B)
Trial: 12655445
Drug: Hydration solution
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydration solution with 70 mEq/l sodium (regimen A)
Trial: 6726650
Drug: Methadone (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (0.5, 1.0, or 2.0 times their regular maintenance dose of 40-60 mg)
Trial: 23273042
Drug: Deprexis web-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deprexis web-based psychological treatment
Trial: 17980884
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ezetimibe and simvastatin
Trial: 12351592
Drug: Antimicrobial lozenge
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial lozenge (Bacitracin, Clotrimazole, Gentamicin)
Trial: 10399232
Drug: Structum and
RxNorm normalized name: Sarocladium strictum
DrugBank: Sarocladium strictum (DB14168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structum and ibuprofen (1200 mg/day) for 6 months
Trial: 29408866
Drug: Ibuprofen only
RxNorm normalized name: Ibuprofen only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen only
Trial: 7480566
Drug: Labetalol (nonselective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (nonselective adrenoceptor antagonist)
Trial: 1979499
Drug: Dopaminergic antidepressant
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic antidepressant drugs
Trial: 1979499
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (gonadotropins, testosterone)
Trial: 1979499
Drug: DA agonist
RxNorm normalized name: DAS-181
DrugBank: DAS-181 (DB15313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA agonist and/or 5‐HT antagonist drugs
Trial: 30835152
Drug: Adjunctive tianeptine
RxNorm normalized name: tianeptine
DrugBank: Tianeptine (DB09289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive tianeptine 37.5 mg/day
Trial: 25154734
Drug: Non-ablative fractional
RxNorm normalized name: OMIDUBICEL NON-CULTURED FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ablative fractional laser treatment (three monthly treatments)
Trial: 25154734
Drug: Non-ablative fractional
RxNorm normalized name: OMIDUBICEL NON-CULTURED FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ablative fractional laser treatment
Trial: 19724023
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/day) plus Orlistat (120 mg, 3 times a day with meals)
Trial: 19724023
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/day) plus Rimonabant (20 mg/day)
Trial: 15631659
Drug: Danazol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (600 mg/day) or Stanazol (6 mg/day) and ATRA (10 mg/day) for at least 3 months
Trial: 11531038
Drug: Aerobic training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerobic training programme (13 weeks, twice a week, 1 hour per session)
Trial: 9603640
Drug: EPx4 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPx4 cycles (etoposide 120 mg/m2 i.v. days 1-3 and cisplatin 80 mg/m2 day 1)
Trial: 9603640
Drug: EPx6 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPx6 cycles (etoposide 120 mg/m2 i.v. days 1-3 and cisplatin 80 mg/m2 day 1)
Trial: 3420161
Drug: Nifedipine 30
RxNorm normalized name: nifedipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 30 mg 3 times daily
Trial: 30296633
Drug: Involuntary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involuntary treatment
Trial: 30296633
Drug: Dependency for
RxNorm normalized name: Vitamin K-dependent protein S
DrugBank: Protein S human (DB13149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dependency for activities of daily life
Trial: 30296633
Drug: Requests for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Requests for involuntary treatment
Trial: 30296633
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of involuntary treatment
Trial: 20103545
Drug: Pregabalin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (300 mg at 90 minutes preoperatively and 150 mg at 12 and 24 hours postoperatively)